04 Oct Golimumab SIMPONI® 50 mg: Important Changes to the Instructions For Use (IFU) for the SmartJect® Autoinjector/Pre-filled Pen
Posted at 13:41h
in
Dear Healthcare Professional
Janssen Pharmaceutica, the holder of the certificate of registration for Simponi 50 mg in agreement with the South African Health Products Regulatory Authority (SAHPRA) would like to inform you of the steps taken to reduce the risks associated with the administration of the product.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
04/10/2023
File Type:
pdf
Category:
Communication To Health Care Professionals